http://www.the-ifoshop.com/pharmaceutical.shtml Pharmaceutical Market Research Reports Global Information, Inc. (C) 2008 Global Information, Inc. 2008-07-25 daily en 2008-07-23 Cutting Edge Information http://www.the-infoshop.com/study/cei69891-oncology.html Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever - pulling together data from our own proprietary PharmaEdge databases, along with hundreds of additional public and private databases worldwide. en 2008-07-23 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70810-biogen-idec.html The Biogen Idec Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Biogen Idec and its partnering interests and activities over the past five years. en 2008-07-23 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70811-abbott-labs.html The Abbott Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Abbott and its partnering interests and activities over the past five years. en 2008-07-23 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70812-alcon-labs.html The Alcon Labs Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Alcon Labs and its partnering interests and activities over the past five years. en 2008-07-23 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70865-allergan-partner.html The Allergan Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Allergan and its partnering interests and activities over the past five years. en 2008-07-23 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70867-amgen-partner.html The Amgen Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Amgen and its partnering interests and activities over the past five years. en 2008-07-23 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70869-astrazeneca.html The AstraZeneca Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand AstraZeneca and its partnering interests and activities over the past five years. en 2008-07-22 BCC Research http://www.the-infoshop.com/study/bc70730-animal-therap.html This BCC Research report, Animal Therapeutics and Diagnostics, provides an overview of products included in this market, and detailed market analyses and competitive environments. en 2008-07-22 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70738-daiichi-sankyo.html The Daiichi Sankyo Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Daiichi Sankyo and its partnering interests and activities over the past five years. en 2008-07-22 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70739-menarini.html The Menarini Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. en 2008-07-22 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70740-mundipharma.html The Mundipharma Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. en 2008-07-22 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70741-ratiopharm-phar.html The Ratiopharm Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Ratiopharm and its partnering interests and activities over the past five years. en 2008-07-22 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70742-servier-pharma.html The Servier Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Servier and its partnering interests and activities over the past five years. en 2008-07-22 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70743-stada-pharma.html The Stada Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Stada and its partnering interests and activities over the past five years. en 2008-07-22 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70868-astellas-partner.html The Astellas Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Astellas and its partnering interests and activities over the past five years. en 2008-07-21 Business Insights http://www.the-infoshop.com/study/rb70667-obesity-drug.html The rising prevalence of obesity is a growing problem in developed countries, with 32% of Americans and 17% of EU residents considered obese in 2008. en 2008-07-21 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70710-barr-pharma.html The Barr Pharmaceuticals Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Barr Pharmaceuticals and its partnering interests and activities over the past five years. en 2008-07-21 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70711-chugai-pharma.html The Chugai Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Chugai and its partnering interests and activities over the past five years. en 2008-07-18 Espicom Business Intelligence http://www.the-infoshop.com/study/es70713-generic-drug.html This report will provide industry planners, commercial developers and the investment community with a thorough review of the operating landscape for generic injectables. The report is packed with primary source information and market forecasts, and takes a balanced view of the players and products that will shape this high value market sector. en 2008-07-16 Select Biosciences, Ltd. http://www.the-infoshop.com/study/sb70562-cancer.html This report provides Cancer Personalized Medicine Market Research, Trends, Analysis. en 2008-07-16 Takeda Pacific http://www.the-infoshop.com/study/tak70563-molecular-diagno.html This report discusses government regulatory initiatives to accelerate the approvals of emerging molecular diagnostics by integrating biomarkers and companion pharmacogenomic tests. Myriad, Veridex, Genomic Health, Agendia and others are gaining traction detecting cancers. Roche' s Affymetrix-based tests measure how patients respond to 30 or more currently marketed drugs. These products enable the emerging field of personalized medicine. The passing of the GINA law in the US might foster the growth of more molecular diagnostics, clinical lab services and other related genetic testing services. en Pharmaceutical Companies Research 2008-07-16 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70592-bigpharma.html The Partnering with Bigpharma: The Definitive Guide to Bigpharma Partnering Interests, Contacts and Agreements report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies. This premier report provides all the information you require to better understand bigpharma partnering. One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company' s business development objectives. Over 200 charts allow quick understanding of each bigpharma companies dealmaking trends over the last four years. en 2008-07-04 Espicom Business Intelligence http://www.the-infoshop.com/study/es70415-biopharma.html This detailed report analyses the market and research environments, assessing risk and identifying opportunity in Indonesia, Malaysia, Singapore, South Korea, Taiwan and Thailand. en 2008-07-01 Decision Resources, Inc. http://www.the-infoshop.com/study/dr65840-sclerosis.html Our Target Product Profi les qualitatively predict the market potential of a drug fulfi lling a key unmet need. en Diabetes Therapeutic Market Research 2008-07-01 Asia Market Information & Development Co. http://www.the-infoshop.com/study/amid69087-cn-insulin-mkt.html China' s demand for Insulin has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1997, 2002 and 2007) and long-term forecasts through 2012 and 2017 are presented. Major producers in China are profiled. en Therapeutics/Diagnosis Market Research 2008-07-01 Asia Market Information & Development Co. http://www.the-infoshop.com/study/amid69089-diagno-reagent.html China' s demand for Diagnostic Reagents has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1997, 2002 and 2007) and long-term forecasts through 2012 and 2017 are presented. Major producers in China are profiled. en Infection Disease Therapeutic Market Research 2008-07-01 Trimark Publications http://www.the-infoshop.com/study/tk70121-hpv-testing.html Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by both external (chemicals, radiation and viruses) and internal (hormones, immune conditions and inherited mutations) factors. Causal factors may act together or in sequence to initiate or promote carcinogenesis. en Pharmaceutical Companies Research 2008-07-01 Trimark Publications http://www.the-infoshop.com/study/tk70124-indian-pharma.html The purpose of this TriMark Publications study is to describe the specific segment of the pharmaceutical market sector called the Indian pharmaceutical industry. en 2008-07-01 Kalorama Information http://www.the-infoshop.com/study/kl70396-long-term-care.html As Kalorama publishes its second edition of this detailed report on the long term care industry and all of its segments, there is no decrease in demand or activity for everything from nursing homes, to home care, to hospices. en 2008-07-01 Insight Pharma Reports (Formerly CHI Advances Reports) http://www.the-infoshop.com/study/cd70599-cancer-bioma.html Cancer Biomarkers: Adoption Is Driving Growth explores the various applications for cancer biomarkers across the healthcare spectrum by presenting the successful adoption of specific biomarkers. These applications include the identification of novel therapeutic targets in cancer drug discovery and uses of cancer biomarkers as surrogate markers for drug efficacy in clinical trials. This report describes a number of factors providing the driving forces behind cancer biomarker growth and commercialization. These factors include requirements to improve screening and early detection, to provide better guidance on therapy and the need to avoid therapy resistance attributes, for understanding cancer staging, response to treatment, and prognosis. en 2008-07-01 Insight Pharma Reports (Formerly CHI Advances Reports) http://www.the-infoshop.com/study/cd70600-medical-need.html The current crisis in antibiotic R&D is attributed to an industry pipeline with few late-stage candidates capable of combating the emergence and spread of novel, drug-resistant bacterial strains. en 2008-07-01 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild70712-actavis-pharma.html The Actavis Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. This report provides all the information you require to better understand Actavis and its partnering interests and activities over the past five years. en 2008-06-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es13877-my-pharma.html The Malaysian healthcare system has grown rapidly since the 1980s, particularly in the private sector, although growth has not been quite as spectacular in recent years. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en Pharmaceutical Companies Research 2008-06-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es15838_solvay.html Operating in the three sectors of Pharmaceuticals, Chemicals and Plastics, Solvay is represented worldwide. This report provides a full review of the company' s activities together with sales forecasts for key products to 2010. Operating in the three sectors of Pharmaceuticals, Chemicals and Plastics, Solvay is represented worldwide. Over 95 per cent of its sales come from outside Belgium and 49 per cent from outside the European Union. en 2008-06-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es15977-hungary-pharma.html This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-06-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es17837-pharma-peru.html This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-06-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es19508_egypt_pharma_market.html The Egyptian pharmaceutical market is the largest in the Middle East. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en Pharmaceutical Companies Research 2008-06-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es42293-daiichi-sankyo.html This report provides a full review of the company's activities together with sales forecasts for key products to 2010. en 2008-06-30 Decision Resources, Inc. http://www.the-infoshop.com/study/dr65833-hypertension.html Our Target Product Profi les qualitatively predict the market potential of a drug fulfi lling a key unmet need. en 2008-06-30 RNCOS E-Services Pvt. Ltd. http://www.the-infoshop.com/study/rnc69051-asian-medical.html The report, Asian Medical Tourism Analysis (2008-2012), provides an insight into the Asian medical tourism market. en Wound Care Market Research 2008-06-30 Technical Insights, Inc. http://www.the-infoshop.com/study/ti70112-wound-healing.html This research service provides the latest trends in wound healing techniques and future developments. en 2008-06-30 Frost & Sullivan http://www.the-infoshop.com/study/fs70267-laboratory.html This research service analyzes the market for reference laboratories within the United States. en Prescription Drugs Market Research Cancer Therapeutic/Diagnosis Market Research 2008-06-30 Technical Insights, Inc. http://www.the-infoshop.com/study/ti70270-cancer-thera.html This research service analyzes the emerging trends in cancer therapies with respect to small molecule drugs and biologicals. en 2008-06-30 Technical Insights, Inc. http://www.the-infoshop.com/study/ti70410-nanotech-healthc.html This service provides an overview of the nanotechnology applications in healthcare. en 2008-06-30 Espicom Business Intelligence http://www.the-infoshop.com/annual/es70758-pharma-latin.html Each country report provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. For each country you will receive 4 completely updated reports sent quarterly, plus a comprehensive report sent annually. en 2008-06-26 Decision Resources, Inc. http://www.the-infoshop.com/study/dr69555-new-warning.html The recombinant erythropoietin-stimulating agents (ESAs) revolutionized treatment of severe anemias, and the anemia market prospered-until accumulating data indicated that ESA treatment may be detrimental to patient survival. en 2008-06-26 Decision Resources, Inc. http://www.the-infoshop.com/study/dr69556-pharma-prices.html In an increasingly globalized pharmaceutical market, drug pricing and reimbursement policies differ markedly among countries. Payers jealously guard their authority to set prices, and both they and government authorities exert growing pressure on manufacturers to cut prices. en Wound Care Market Research 2008-06-26 Frost & Sullivan http://www.the-infoshop.com/study/fs69880-wound-care.html The objective of this research service is to evaluate the present state of the emerging technologies in the U.S. advanced wound care markets and present a forecast and analysis of the revenues. en Bone Disease Treatment Market Research 2008-06-26 Frost & Sullivan http://www.the-infoshop.com/study/fs69882-us-osteoporosis.html This research service covers the U.S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bisphosphonates, selective estrogen receptor modulators, calcitonins, parathyroid hormones, and novel therapeutic approaches. Major market challenges, drivers, and restraints and identified and discussed. en Drug Delivery(DDS) Market Research 2008-06-26 Frost & Sullivan http://www.the-infoshop.com/study/fs69888-eu-drug-deli.html The research services deals with the a strategic insight in to the opportunity in the drug delivery markets especially pulmonary and transdermal segments in Europe. Market drivers, restraints, industry challenges, key trends, revenue forecasts and strategic recommendations are provided in detail. en Cancer Therapeutic/Diagnosis Market Research 2008-06-25 Koncept Analytics http://www.the-infoshop.com/study/koan69481-cancer-mkt.html The report throws light on the different types of cancers, new cases and deaths. It also analyzes the global radiation therapy and oncology market. It starts with a discussion of the worldwide diagnosis and therapy equipment market and then analyzes cancer drugs market. The report also discusses the major players with a discussion of their key business strategies. en 2008-06-24 Decision Resources, Inc. http://www.the-infoshop.com/study/dr69557-biotech-invest.html Promising new therapies and drug discovery approaches are within reach, but the pharmaceutical and biotechnology industries face unprecedented scientifi c, business, and regulatory challenges. en 2008-06-20 Decision Resources, Inc. http://www.the-infoshop.com/study/dr69380-cystic-fibrosis.html The cystic fi brosis (CF) market is poised for signifi cant change. The next generation of CF treatments all target the central mechanism responsible for organ damage in CF. en In Vitro Diagnostics Market Research 2008-06-18 Frost & Sullivan http://www.the-infoshop.com/study/fs69154-european-ivd.html This Frost & Sullivan research service titled Western European IVD Markets provides an overview of the IVD markets in Europe, together with the revenues for each market. en Therapeutics/Diagnosis Market Research Infection Disease Therapeutic Market Research 2008-06-18 Frost & Sullivan http://www.the-infoshop.com/study/fs69156-african-disease.html Research was carried out on the infectious disease diagnostics markets in Kenya, Tanzania and Uganda. en Generic Drugs Market Research 2008-06-18 Espicom Business Intelligence http://www.the-infoshop.com/study/es69402-us-pharma.html This extensive report provides a unique analysis of the likely impact of generic competition in the US pharma market. en 2008-06-18 Health Industry Insights http://www.the-infoshop.com/study/heal69513-healthcare.html This Health Industry Insights report finds that an explosion of healthcare payer mergers, acquisitions, new consumer-focused business models, and increasing competitions creates new demands for high-performing enterprise administrative and clinical solutions. en 2008-06-17 Decision Resources, Inc. http://www.the-infoshop.com/study/dr69316-improving-return.html Pharmaceutical marketing is in trouble-campaigns are not as effective as they should be, and costs have spiraled out of control. Marketing expenditures are the single largest corporate investment at most pharmaceutical companies and are running at almost twice the spend of R&D. en 2008-06-17 Datamonitor http://www.the-infoshop.com/study/dc69322-non-hormonal.html This report provides Menopausal Symptoms Non-hormonal Treatments Market Research, Trends, Analysis. en 2008-06-17 Datamonitor http://www.the-infoshop.com/study/dc69323-symptoms.html This report provides Menopausal Symptoms Market Research, Trends, Analysis. en Drug Delivery(DDS) Market Research 2008-06-16 Business Insights http://www.the-infoshop.com/study/rb69059-drug-delivery.html Over the last decade, the drug delivery industry has evolved to become a key area in the development of value added pharmaceutical products. en Neurodegenerative Disease Market Research 2008-06-16 Datamonitor http://www.the-infoshop.com/study/dc69529-neuropathic.html The neuropathic pain market is forecast to almost triple to over $6.3 billion by the end of the forecast period in 2017. The growth in the market is spurred on by the uptake of Pfizer' s Lyrica (pregabalin), forecast to reach almost $3 billion in sales by 2017. Vimpat is the most promising pipeline drug, forecast to take some $480m by 2017. en Neurodegenerative Disease Market Research 2008-06-16 Best Practices, LLC http://www.the-infoshop.com/study/bepr69539-requip-case.html This case study reviews the strategy and tactics utilized by GlaxoSmithKline for the Parkinson' s indicated product, Requip/Adartrel, to manage the life and commercial success of the brand through re-branding for treatment of Restless Leg Syndrome (RLS). Executives and managers can use this research to gain insights into methods for reinvigorating sales of a mature product. en Mental Disease Therapeutic Market Research 2008-06-16 Best Practices, LLC http://www.the-infoshop.com/study/bepr69540-cymbalta-case.html This case study reviews the strategy and tactics utilized by Eli Lilly for the depression indicated product, Cymbalta, to successfully penetrate a crowded market with a product having a new mechanism of action (MOA). Pharmaceutical executives can use this study to gather insights into various tactics for successfully launching a product with a new MOA into a challenging market. en Drug Discovery Market Research 2008-06-16 Best Practices, LLC http://www.the-infoshop.com/study/bepr69541-best-practices.html Long and costly product development cycles make it essential for pharmaceutical companies to maximize use of limited staff and resources for the development of compounds with the greatest potential market value. Leading companies are integrating commercial insights earlier and earlier into the new product development process in an effort to more quickly identify and target promising compounds, reduce development cycle time, focus resources for greatest impact and increase their potential for launching a blockbuster drug. en 2008-06-12 Frost & Sullivan http://www.the-infoshop.com/study/fs69034-opthalmology.html This research service provides an insight into the South African Ophthalmology Pharmaceuticals Market. en 2008-06-11 Decision Resources, Inc. http://www.the-infoshop.com/study/dr68813-orphan-drug.html The glaucoma market has not seen any new mechanisms for treatment since the launch of prostaglandin analogues in the mid 1990s. en 2008-06-11 Decision Resources, Inc. http://www.the-infoshop.com/study/dr68814-pharma-pricing.html France invests heavily in maintaining its outstanding universal healthcare system. However, drug prices in France-already among the lowest in Europe-are declining as a result of tough cost-containment measures targeted primarily at pharmaceutical companies. en 2008-06-05 Decision Resources, Inc. http://www.the-infoshop.com/study/dr68536-life-spans.html The commercial potential of products in development is vitally import to the pharmaceutical industry, which is now beset with productivity concerns, looming patent expiries, and declining growth rates. en 2008-06-05 Decision Resources, Inc. http://www.the-infoshop.com/study/dr68537-opportunities.html Diagnostics can be used to identify subgroups of patients who may or may not benefi t from a companion drug, who may have adverse reactions to that drug, or who may require different doses of that drug because of their particular metabolic activity. en Cancer Therapeutic/Diagnosis Market Research 2008-06-05 Frost & Sullivan http://www.the-infoshop.com/study/fs68556-lung-cancer.html This research service analyses the European Lung cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recommendations. en 2008-06-04 Frost & Sullivan http://www.the-infoshop.com/study/fs68521-infection-control.html This research service looks at issues and trends in infection control in Europe. The report gives an introduction to Hospital-Acquired Infections and associated prevalence data. The report then looks at emerging challenges and trends, as well as industry responses to these challenges. en 2008-06-03 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild67664-clinical-stage.html The report provides a detailed understand and analysis of how and why companies enter clinical stage partnering deals. en Pharmaceutical Companies Research 2008-06-03 Business Insights http://www.the-infoshop.com/study/rb67670-contract.html Drug manufacture now typically accounts for 25% of company revenues and achieving agility in the manufacturing process has become essential for pharma companies hoping to align their supply chains with constant shifts in global product demand. en 2008-06-03 Frost & Sullivan http://www.the-infoshop.com/study/fs68525-us-radiopharma.html This research service focuses on the U.S. Radiopharmaceutical Agents markets, which is segmented into cardiology diagnostics, other diagnostics, FDG, and therapeutic market segments. The research service covers the markets for these radiopharmaceutical agents over an eleven year period, from 2004 to 2014, with the base year being 2007. en Cancer Therapeutic/Diagnosis Market Research 2008-06-03 BioSeeker Group AB http://www.the-infoshop.com/study/bg68552-antibodies.html This report aims to analyze the current and future potential of cancer antibodies by examining key fundamentals across the entire pipeline of antibody drug candidates. en Pharmaceutical Companies Research 2008-06-02 Cutting Edge Information http://www.the-infoshop.com/study/cei67620-accelerating.html Deal-making is an established strategy for filling company pipelines, raising cash, expanding portfolios and driving long-term revenue. en 2008-06-01 Asia Market Information & Development Co. http://www.the-infoshop.com/study/amid66887-penicillin.html This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. en 2008-06-01 Asia Market Information & Development Co. http://www.the-infoshop.com/study/amid66901-cn-cephalosporin.html China' s demand for Cephalosporins has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1997, 2002 and 2007) and long-term forecasts throught 2012 and 2017 are presented. Major producers in China are profiled. en 2008-06-01 MarketData Enterprises, Inc. http://www.the-infoshop.com/study/md67131-sleep-market.html This report provides U.S. Sleep Market Research, Trends, Analysis. en 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es13889-bd-pharma.html Bangladesh is one of the ten most populous countries in the world. It is also one of the poorest. Access to even the most basic of healthcare provision remains sub-standard, despite the ongoing efforts of the government, aided by considerable international assistance. Adequate secondary or tertiary care is beyond the reach of all but a very few people. Government hospitals are often little more than clinics, and suffer from severe shortages of trained staff. There is a growing private hospital sector, largely based in Dhaka, which caters for the well-off. It is in the private sector where the most advanced services are located, and where almost all pharmaceutical demand is found. en 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es15736-cz-pharma.html The Czech pharmaceutical sector remains one of the better regional prospects for overseas suppliers, being relatively wealthy and largely reliant on imported medicines. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es19123-pharma-taiwan.html This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es20114_chile_pharmaceutical.html The Chilean pharmaceutical market is the sixth largest market in the region, after Mexico, Brazil, Argentina, Venezuela and Colombia. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es20789_spain_pharmaceutical.html The Spanish pharmaceutical market is the fifth largest in the EU-15 and the seventh in the world. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es22704_denmark_pharmaceutical.html This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. en 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es24375_novo_nordisk_pharma.html Novo Nordisk is a biotech-based healthcare company with a broad diabetes product portfolio. It also has a leading position in haemostasis management, growth hormone therapy and hormone replacement therapy. en Cancer Therapeutic/Diagnosis Market Research 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es51959-alcon.html This new strategic analysis report provides a complete and critical review of the company and includes unique and independent assessments and forecasts of key products. en Pharmaceutical Companies Research 2008-05-31 Espicom Business Intelligence http://www.the-infoshop.com/study/es66458-shire.html Shire is a leading specialty pharmaceutical company traditionally focused on the treatment of attention deficit hyperactivity disorder (ADHD) and gastrointestinal disorders. en Cancer Therapeutic/Diagnosis Market Research 2008-05-30 BCC Research http://www.the-infoshop.com/study/bc63253-therapies.html This report provides Global Cancer Therapies Market Research ,Trends, Analysis. en 2008-05-30 WWMR, Inc. http://www.the-infoshop.com/annual/ww66857-pain-clinic.html Pain control has become a high priority due to the rise in patient expectations for quality of life. en In Vitro Diagnostics Market Research 2008-05-30 RNCOS E-Services Pvt. Ltd. http://www.the-infoshop.com/study/rnc67054-vitro-diagnostic.html The In Vitro Diagnostics (IVD) Industry represents one of the most lucrative segments in global healthcare industry. en 2008-05-30 The Freedonia Group http://www.the-infoshop.com/study/fd67218-pharm-packaging.html It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 by type and by market. en Infection Disease Therapeutic Market Research 2008-05-30 RI Technologies http://www.the-infoshop.com/study/rit70322-prions.html Prions report gives an insight into the market for Prion Deactivation technologies, Post Mortem Testing for BSE and Prion Reduction Filters. en Veterinary Medicine Market Research Vaccines Market Research 2008-05-29 RI Technologies http://www.the-infoshop.com/study/rit67098-veterinary.html Veterinary Vaccines report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. en 2008-05-29 Global Markets Direct http://www.the-infoshop.com/study/labd68111-wound-care.html This report is an essential source for key information and data relating to the Global wound care devices market. en 2008-05-29 Decision Resources, Inc. http://www.the-infoshop.com/study/dr68441-indications.html In this report, we discuss the treatment challenges that confront physicians and patients and review current and emerging diagnostic tests that are expected to change the way in which psychiatric diseases are diagnosed. en 2008-05-28 Datamonitor http://www.the-infoshop.com/study/dc67677-pricing.html Governments and payers across the seven major markets are implementing cost-cutting initiatives to combat escalating healthcare costs, putting even greater pressure on pharma companies. In addition to the credit crunch, ever fewer novel products are coming to market, contributing to the declining return on investment. en 2008-05-27 Business Insights http://www.the-infoshop.com/study/rb67000-clinical-res.html Post-marketing studies are undertaken to delineate additional clinical information concerning a drug' s risks, benefits, and optimal use. Industry stakeholders acknowledge that research undertaken in order to obtain marketing authorization (MA) does not always coincide with initiatives to ensure that the product is subsequently placed in its ideal or intended market context. en Therapeutics/Diagnosis Market Research 2008-05-27 Business Insights http://www.the-infoshop.com/study/rb67002-clinical-trial.html This report provides Innovative Clinical Trial Design & Management Market Research, Trends, Analysis. en 2008-05-27 Decision Resources, Inc. http://www.the-infoshop.com/study/dr68809-reimbursement.html The pharmaceutical industry faces challenging times in the Japanese market. The government has expressed its desire to reward the development of innovative medicines and has promised more-generous price premiums for innovative drugs. en 2008-05-23 Datamonitor http://www.the-infoshop.com/study/dc67207-pipeline-insight.html Stroke is one of the top three causes of death and its incidence in the seven major markets is expected to increase in the next ten years because of an aging population. Long term disability caused by stroke is a major economic burden on healthcare systems, current treatment options are limited and general awareness of stroke is poor. en 2008-05-23 Datamonitor http://www.the-infoshop.com/study/dc67208-cox-2-pipeline.html With several recent non-approvable decisions in the osteoarthritis market since 2006, Datamonitor has updated its forecast to account for the effect on the market. We have revised the market outlook over the next 10 years using the latest IMS data. We expect the market to grow steadily, with a CAGR from 2007 to 2017 of 3.2%, to reach sales of nearly $5.5 billion in 2017. en In Vitro Diagnostics Market Research 2008-05-21 Kalorama Information http://www.the-infoshop.com/study/kl65934-ivd.html This completely updated edition of Kalorama' s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD. en 2008-05-20 Espicom Business Intelligence http://www.the-infoshop.com/study/es66996-pharmaceutical.html Thousands of key market facts and statistics at your fingertips! Bringing together a comprehensive range of often difficult to source information in one publication, the Fact Book includes a global overview, five regional overviews and extensive data on 64 countries. en Vaccines Market Research Cancer Therapeutic/Diagnosis Market Research 2008-05-19 BioSeeker Group AB http://www.the-infoshop.com/study/bg66947-cancer-vacci.html This report aims to analyze the current and future potential of cancer vaccines by examining key fundamentals across the entire pipeline of cancer vaccine drug candidates. BioSeeker has identified three fundamental dimensions to outline the competitive landscape within the pharmaceutical industry; compound type, therapy area and target type. For the purposes of this report, BioSeeker is focusing on therapeutic cancer vaccines and as such the commercialized and pipeline prophylactic agents have not been included. en 2008-05-19 Decision Resources, Inc. http://www.the-infoshop.com/study/dr66965-orphan-disease.html Only one drug is approved for the treatment of ALS, and its only benefi t is a modest increase in survival time. en 2008-05-19 Arrowhead Publishers http://www.the-infoshop.com/study/arr66971-reimbursement.html Evidence-based medicine is defined as an attempt to use standards from scientifically-collected evidence to improve medical practices by assessing risks and benefits of treatments and/or the lack of treatments. en 2008-05-16 Visiongain http://www.the-infoshop.com/study/kt70137-indian-pharma.html The pharmaceutical industry is one of the fastest growing sectors in Indian economy. Visiongain predicts that market for pharmaceuticals in India has strong potential for increased growth from 2008 right through to 2023. en Veterinary Medicine Market Research 2008-05-15 Trimark Publications http://www.the-infoshop.com/study/tk66625-animal-health.html This study offers a detailed examination of the shape of the animal health products market globally over the next several years specific to antibacterials, analyzing both the livestock and companion animal markets en 2008-05-13 Frost & Sullivan http://www.the-infoshop.com/study/fs66647-antibodies.html This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. en 2008-05-12 Frost & Sullivan http://www.the-infoshop.com/study/fs66649-amplification.html This research service gives a detailed analysis of the NAT reagents market for clinical applications in Europe from 2004-2014 en Pharmaceutical Companies Research 2008-05-08 Datamonitor http://www.the-infoshop.com/study/dc66908-drug-repositioning.html Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly harsh market environment. en 2008-05-07 Frost & Sullivan http://www.the-infoshop.com/study/fs66479-electric-drive.html This research service aims to provide an in depth analysis of various aspects of the electric drives market in European pharmaceutical industry. The market has been covered product wise, application wise, power rating wise and geography wise together with providing details on the competitive structure, distribution channels and pricing trends. en 2008-05-07 Decision Resources, Inc. http://www.the-infoshop.com/study/dr66538-opportunities.html Although the obsessive-compulsive disorder (OCD) market is small and OCD diagnosis rates are low, this market is characterized by substantial unmet need and commercial opportunity. en 2008-05-07 Decision Resources, Inc. http://www.the-infoshop.com/study/dr66539-reimbursement.html The country' s leading pharmaceutical-industry association has warned the Italian government that without a radical change in Italian pharmaceutical policy, the industry' s competitiveness in the global market will be severely compromised, and Italy will soon be overtaken in the global rankings by other major pharmaceutical markets. en 2008-05-05 Decision Resources, Inc. http://www.the-infoshop.com/study/dr66537-opportunity.html Asian economic might is growing, and the Asian pharmaceutical markets and industry are growing along with it. en 2008-05-02 Global Markets Direct http://www.the-infoshop.com/study/labd66589-diagnostics-ind.html This report is an essential source for in-depth information and data relating to the USA In Vitro Diagnostics devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the In Vitro Diagnostics in USA en OTC Drug Market Research 2008-05-01 Kalorama Information http://www.the-infoshop.com/study/kl65943-otc-pharma.html Over-the-counter (OTC) drugs are well situated to capitalize on worldwide economic conditions. Customers in the US and in the world under time constraints and tight budgets prefer OTC and are opting to self-medicate where possible. en Wound Care Market Research 2008-05-01 Kalorama Information http://www.the-infoshop.com/study/kl65945-wound-care.html This report provides World Wound Care Market Research, Trends, Analysis. en Drug Discovery Market Research Cancer Therapeutic/Diagnosis Market Research 2008-05-01 Kalorama Information http://www.the-infoshop.com/study/kl66482-drug-discovery.html 2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. en Cancer Therapeutic/Diagnosis Market Research 2008-05-01 Trimark Publications http://www.the-infoshop.com/study/tk66626-cancer-thera.html This TriMark Publications report provides an overview of the global market for cancer therapeutics. The examination focuses on the efforts of biotechnology companies and pharmaceutical firms to incorporate new technologies for developing anti-cancer drugs into their corporate strategies. This study examines cancer therapeutic products now on the market, as well as those currently under development that might be commercialized in the near future. Additionally, the report profiles a number of firms that are actively involved in marketing and developing of products to be used in the treatment of cancer-both large multinational corporations. The analysis also provides an overview of the disease and data on cancers by site or type. It provides incidence and mortality data for different types of the disease. In addition, the report provides a summary of each of the therapies that are being used to treat cancer. en In Vitro Diagnostics Market Research 2008-05-01 Trimark Publications http://www.the-infoshop.com/study/tk66628-diagno-testing.html The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing. This study examines clinical measurement devices and their reagents and supplies as used in hospitals, clinics and doctor' s offices. This examination is arranged to provide the reader with an overview of the outstanding diagnostic test market segments of cardiac care, with evidence that these segments are poised for high future growth. en 2008-05-01 Mintel International Group Ltd, http://www.the-infoshop.com/study/mt67641-cigarettes.html Some 12 million people smoke in the UK (around a quarter of adults) - this translates to around £25,000 per minute literally going up in smoke. The nicotine rush is powerful and pleasurable, and a force to be reckoned with. Over half of smokers claim they want to give up, but only four out of ten are actually trying to give up, and yes, some do actually kick the habit permanently. en OTC Drug Market Research 2008-05-01 Mintel International Group Ltd, http://www.the-infoshop.com/study/mt68889-us-cough.html The cough and throat remedies market has undergone significant fluctuations during 2002-07, due mostly to the relative severity of annual cold/flu seasons. en Drug Discovery Market Research 2008-05-01 Insight Pharma Reports (Formerly CHI Advances Reports) http://www.the-infoshop.com/study/cd69144-brain-barrier.html CNS diseases are a major focus of the pharmaceutical industry, with CNS drugs representing some of its most successful products. These include Pfizer' s Zoloft (sertraline, for treatment of depression and certain types of anxiety disorders), Lilly' s Cymbalta (duloxetine, for treatment of depression) and Bristol-Myers Squibb' s/Otsuka' s Abilify (aripiprazole, for treatment of bipolar disorder and schizophrenia). However, drug discovery and development researchers experience difficulty developing CNS drugs that complete clinical trials and win regulatory approval - especially drugs which meet major unmet needs in the CNS area, such as Alzheimer' s disease. The vast majority of drugs fail to cross the BBB, which is causing a major bottleneck in successful development of CNS drug candidates. This report reviews the discovery, design and development of small- and large-molecule drugs that can efficiently cross the BBB. This includes more traditional, medicinal chemistry-based methods, as well as approaches that exploit carrier-mediated transport (CMT) and receptor-mediated transport (RMT). Also covered in the report is use of nanoparticle technology to enable BBB penetration. Further, the report presents in vitro and in vivo assays as well as imaging methods to ascertain a drug' s ability to cross the BBB and reach its target. en 2008-05-01 Insight Pharma Reports (Formerly CHI Advances Reports) http://www.the-infoshop.com/study/cd69145-cardiotoxicity.html At least 50 companies have a claimed product or service relevant to cardiotoxicity screening, of which 29 have some clear focus on proarrhythmic cardiotoxicity or ion channel screening. en 2008-05-01 BCC Research http://www.the-infoshop.com/study/bc70650-pharmaceutical.html This study examines world pharmaceutical markets and provides pertinent information about sales and production of pharmaceutical products, as well as information about national healthcare systems and drug pricing policies. en Pharmaceutical Companies Research 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es13856-boehringer.html This report provides a full review of the company's activities together with sales forecasts for key products to 2010. en 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es15976-hk-pharma.html Hong Kong is really a city state, but the high level of wealth means that its healthcare provisions are of the very highest standard. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es15978-nz-pharma.html The pharmaceutical market in New Zealand is experiencing very limited growth due to the country' s relatively low-growth economy and ageing population. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. en 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es17357-pharma-australia.html Australia represents a highly advanced pharmaceutical market. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. en 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es17360-pharma-sweden.html This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. en Pharmaceutical Companies Research 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es20340_pharmaceuticals.html Headquartered in New York, Bristol-Myers Squibb is involved in the research and development of treatments for conditions such as heart disease, high blood pressure, stroke, diabetes, cancer, HIV/AIDS, depression, schizophrenia and pain. en Pharmaceutical Companies Research 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es42298-otsuka.html This report provides a full review of the company's activities together with sales forecasts for key products to 2010. en Pharmaceutical Companies Research 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es42301-shionogi.html This report provides a full review of the company's activities together with sales forecasts for key products to 2010. en 2008-04-30 RNCOS E-Services Pvt. Ltd. http://www.the-infoshop.com/study/rnc65903-pharma-mkt.html The report Emerging Pharmaceutical Markets Globally provides an exhaustive overview of the pharmaceutical markets in the E7 countries (Brazil, Russia, India, China, Mexico, Turkey and Indonesia). This Report provides a detailed account of the factors that are redefining the structure and composition of the global pharmaceutical market and causing a shift in growth from the mature markets to the emerging ones. Statistics and analysis regarding market size, growth, structure, exports and imports, therapy mix, share of branded and generic drugs, healthcare financing, market share of key players, as well as key drivers and restraints and trends in technology development have been thoroughly analyzed in this report. en Pharmaceutical Companies Research 2008-04-30 Cutting Edge Information http://www.the-infoshop.com/study/cei65924-reach-of-ci.html Pharmaceutical competitive intelligence (CI) helps drive decision-making processes across an organization. As a forward-thinking, proactive support function, CI influences business development and brand management, among other areas. CI identifies market risks as well as business growth opportunities. en 2008-04-30 Decision Resources, Inc. http://www.the-infoshop.com/study/dr65941-reimbursement.html This report provides Pharmaceutical Pricing, Reimbursement, and Prescribing News in the First Quarter of 2008. en Wound Care Market Research 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es66245-wound-care.html This report provides analysis of the wound care sector by technology type, assessing competing products and profiling the companies involved. en Drug Discovery Market Research 2008-04-30 Espicom Business Intelligence http://www.the-infoshop.com/study/es66920-cardiovasc-drug.html This market analysis provides an unparalleled comparative study of key research in 6 leading cardiovascular market sectors, unique and original market forecasts and critical analyses and competitive ratings for upcoming products. Cardiovascular disease is a global problem. In the developed world, its prevalence is linked to our increasingly unhealthy lifestyle, with risk factors including lack of exercise, overweight and obesity, and smoking. These are also linked to diabetes which increases the risk of developing heart disease. en Diabetes Therapeutic Market Research Obesity Treatment Market Research 2008-04-30 Visiongain http://www.the-infoshop.com/study/kt67195-lipitor.html This report provides Lipitor Market Research, Trends, Analysis. en Generic Drugs Market Research Neurodegenerative Disease Market Research 2008-04-25 Espicom Business Intelligence http://www.the-infoshop.com/study/es66349-generic-drugs.html This important new strategic report from Espicom evaluates the CNS generic drug market and provides detailed assessment and forecast for leading products by value to 2012, patent expiry opportunities to 2015 and competitive evaluation. en 2008-04-22 Frost & Sullivan http://www.the-infoshop.com/study/fs65336-pharma-biotech.html This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe. en 2008-04-21 CurrentPartnering, a division of Wildwood Ventures Limited http://www.the-infoshop.com/study/wild65276-biopharma.html The report provides a detailed understand and analysis of how and why companies enter manufacturing and supply deals. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66296-brain-cancer.html Despite the heavy investment made into brain cancer research, primary brain cancer, with glioblastoma multiforme being the most aggressive and most common form, remains one of the most deadly diseases in the developed world. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66297-antibodies.html The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic antibodies. en Drug Discovery Market Research Cancer Therapeutic/Diagnosis Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66299-breast-cancer.html Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66300-oncology.html Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells. en Drug Discovery Market Research Cancer Therapeutic/Diagnosis Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66301-prostate-cancer.html Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. en Drug Discovery Market Research Cancer Therapeutic/Diagnosis Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66302-cancers-drug.html Unmet needs across the hematological malignancies remain high, with most traditional therapies conferring low levels of specificity and high toxicity. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66303-leukemia-drug.html Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. en Drug Discovery Market Research Cancer Therapeutic/Diagnosis Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66304-oncology.html There are today more than 200 anti-angiogenic/vascular disruptive/vascular targeting agents drugs in oncology, from early preclinical to marketed drugs. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66305-immunotherapy.html Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66307-lymphoma-drug.html Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. en Drug Discovery Market Research Vaccines Market Research Cancer Therapeutic/Diagnosis Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66331-drug-pipeline.html Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. en Drug Discovery Market Research Cancer Therapeutic/Diagnosis Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66332-lung-cancer.html Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D and chemotherapy use, the median overall survival of NSCLC patient' s remains below 12 months. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66333-protein.html Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. en Drug Discovery Market Research Cancer Therapeutic/Diagnosis Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66334-colorectal-cancer.html Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66335-melanoma-drug.html Melanoma comprises just 5% of all skin cancers but it is the most deadly. High unmet needs still persist for this tumor type and despite three decades of extensive R&D, five-year survival of advanced patients remains below 20%. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66336-bladder-cancer.html According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate is 94%. en Cancer Therapeutic/Diagnosis Market Research Drug Discovery Market Research 2008-04-20 BioSeeker Group AB http://www.the-infoshop.com/study/bg66337-renal-cancer.html The high existing unmet need in the treatment of renal cancer is reflected by the poor prognosis of patients with advanced stage disease, five- year survival rates with existing cytokine therapy being less than 20% (RCC) in this patient cohort.